Document is current

Article History

First Online: 9 August 2018

Ethics approval and consent to participate

: The approval from the Ethical Committee (EC) of the coordinating center (Fondazione IRCCS Ca′ Granda, Ospedale Maggiore Policlinico, Milan, Italy) has been obtained on March 6th, 2017 (#81_2017bis). All the IRENE centers are required to obtain local EC approval before entering the registry. All enrolled patients (up to 20th July 2018) gave their written informed consent to participate in the registry.

: Not applicable.

: Prof. Aliberti received grants from Insmed and Fisher and Paykel, and consultancy/lecture fees from Bayer Healthcare, Grifols, Zambon, Chiesi, Horizon Pharma and Insmed. Prof. Chalmers reports grants from Bayer Healthcare, Glaxosmithkline, Boehringer Ingelheim, Astrazeneca, Insmed, Pfizer and Grifols, and personal fees from Napp and Chiesi. Dr. Codecasa received consultancy fees from Insmed. Dr. Loebinger have received consultancy and lecture fees from Insmed. Prof. Haworth received unrestricted educational grants, speaker fees and consultancy fees from Insmed. Prof. Gori received grants/research supports from Abbvie, Astellas, BMS, Boeringher, Gilead, Janssen, MSD, Novartis, Pfizer, Roche and ViiV, honoraria or consultation fees from BMS, Gilead, Janssen, MSD, Novartis and ViiV, travel grant/supports from BMS, Gilead, Jansen, and ViiV, and he participated in a company sponsored speaker’s bureau for Gilead. Dr. Winthrop received grants and consulting from Insmed. All the other authors declare that they have no competing interests.Prof. Francesco Blasi is Editor-in-Chief of Multidisciplinary Respiratory Medicine, whereas Profs. Stefano Aliberti, Giovanni Sotgiu, Stefano Nardini are Associate Editor of Multidisciplinary Respiratory Medicine. In addition, Prof. Stefano Aliberti and Prof. James Chalmers are Guest Editors of the Supplement on Bronchiectasis.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.